Hillsdale Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-45,032	Closed	-$3.29M	–	645
2024 Q1	$3.29M	Buy	45,032 +3,500	+8%	+$256K	0.26%	156
2023 Q4	$2.97M	Sell	41,532 -6,100	-13%	-$436K	0.24%	157
2023 Q3	$2.85M	Sell	47,632 -6,100	-11%	-$366K	0.26%	144
2023 Q2	$3.87M	Buy	+53,732	New	+$3.87M	0.36%	120